Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City

Launched by ZHONGSHAN HOSPITAL (XIAMEN), FUDAN UNIVERSITY · Sep 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying Gastroesophageal Reflux Disease (GERD), a condition where stomach acid frequently flows back into the esophagus, causing symptoms like heartburn and regurgitation. The researchers aim to understand the patterns and risk factors related to GERD in Xiamen City. They want to learn more about how GERD affects people and the potential risks, including a serious condition called Barrett's Esophagus, which can lead to cancer if left untreated.

To participate in this trial, you should be a permanent resident of Xiamen and have experienced typical GERD symptoms, such as mild heartburn or regurgitation, at least twice a week for the last three months. Participants will need to undergo an upper endoscopy (a procedure to examine the esophagus) and fill out a questionnaire. It’s important to note that certain individuals, like those with severe health issues or previous stomach surgery, may not be eligible to join. If you decide to participate, you will be helping researchers gather important information that could improve the understanding and treatment of GERD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients had experienced typical reflux symptoms, i.e., mild heartburn and/or regurgitation symptoms, for at least 2 days per week or moderate/severe reflux symptoms for more than 1 day per week during the previous 3 months and had upper endoscopy examinations in the previous month.
• • Cooperate with the questionnaire survey.
• • Volunteer and sign the informed consent form.
• • Permanent residents in Xiamen.
• Exclusion Criteria:
• • Malignant tumor.
• • Partial or total gastrectomy.
• • Failing to cooperate with the investigation because of the factors such as education level and language intelligence disorder, etc.
• • Patients with severe heart, lung, kidney, liver, blood, nerve, endocrine and mental system diseases.
• • Patients with mental retardation, etc.